Compare CDNA & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | EEX |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | 821 |
| Industry | Medical Specialities | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 979.7M |
| IPO Year | 2007 | N/A |
| Metric | CDNA | EEX |
|---|---|---|
| Price | $21.86 | $4.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $27.60 | $7.70 |
| AVG Volume (30 Days) | ★ 672.4K | 14.8K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $16.01 | $7.49 |
| Revenue Next Year | $11.31 | $6.81 |
| P/E Ratio | ★ N/A | $236.96 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $3.32 |
| 52 Week High | $23.24 | $5.45 |
| Indicator | CDNA | EEX |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 58.48 |
| Support Level | $16.63 | $4.81 |
| Resistance Level | $23.24 | $5.02 |
| Average True Range (ATR) | 1.39 | 0.18 |
| MACD | 0.36 | 0.03 |
| Stochastic Oscillator | 81.12 | 72.00 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States, with operations in the United Kingdom (U.K.), France, and other markets. The company is engaged in three complementary business lines: Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division provides B2B e-commerce and digital merchandising solutions to manufacturers and retailers. Emerald's key revenue is derived from the Connections business, its only reportable segment.